Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Express Scripts
Merck
Harvard Business School
Cipla
Johnson and Johnson
McKesson
Deloitte
Argus Health
Fuji

Generated: January 22, 2018

DrugPatentWatch Database Preview

HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE Drug Profile

« Back to Dashboard

When do Homatropine Methylbromide And Hydrocodone Bitartrate patents expire, and what generic alternatives are available?

Homatropine Methylbromide And Hydrocodone Bitartrate is a drug marketed by Actavis Elizabeth, Avanthi Inc, and Novel Labs Inc. and is included in three NDAs.

The generic ingredient in HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE is homatropine methylbromide; hydrocodone bitartrate. There are five drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the homatropine methylbromide; hydrocodone bitartrate profile page.
Summary for HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE
Drug patent expirations by year for HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE
Pharmacology for HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE
Drug ClassOpioid Agonist
Mechanism of ActionOpioid Agonists

US Patents and Regulatory Information for HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE homatropine methylbromide; hydrocodone bitartrate TABLET;ORAL 040295-001 Dec 1, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Avanthi Inc HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE homatropine methylbromide; hydrocodone bitartrate TABLET;ORAL 207176-001 Aug 7, 2017 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novel Labs Inc HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE homatropine methylbromide; hydrocodone bitartrate TABLET;ORAL 091528-001 Apr 20, 2011 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Dow
Deloitte
Citi
UBS
Teva
Johnson and Johnson
Cerilliant
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot